Zugriffe | |
---|---|
Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 303 |
Juni 2024 | Juli 2024 | August 2024 | September 2024 | Oktober 2024 | November 2024 | Dezember 2024 | |
---|---|---|---|---|---|---|---|
Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 6 | 10 | 8 | 13 | 4 | 6 | 1 |
Zugriffe | |
---|---|
3_Chapter3_Materials_Methods.pdf | 235 |
6_Chapter6_References.pdf | 225 |
1_Chapter1_Introduction_aims_objectives.pdf | 190 |
7_Chapter7_Appendices_Aknowledgements.pdf | 159 |
0_Title_Index.pdf | 148 |
2_Chapter2_Literature_review.pdf | 121 |
4_Chapter4_Results_Discussions.pdf | 95 |
5_Chapter5_Summary_Zusammenfassung.pdf | 74 |